Global Biobanking Equipment Market Continues to Grow as Brooks Life Sciences launches BioStore IIIv, an automated next-generation alternative to manual -80°C mechanical freezers

Biobanking Equipment Market

 Biobanking is a type of biorepository that stores biological samples for research purposes. Over the years biobanks have become a key resource in medical research and have supported contemporary research activities such as personalized medicine and genomics. Generally, biobanks can offer access to researchers to data representing a vast pool of population, which also has sparked questions on research ethics and privacy. Mostly, biobanks have been used in human genetics research.

Growing prevalence of chronic diseases is expected to drive growth of the global biobanking equipment market. According to the Centers for Disease Control and Prevention (CDC), in the U.S., in 2020, around 108 million people have hypertension, which is defined as systolic blood pressure. According to the World Health Organization (WHO), in 2016, around 251 million cases of COPD were diagnosed across the globe, while around 3.17 million deaths were caused due to COPD in 2015. According to the Cystic Fibrosis Foundation (CFF), over 1,000 new cases of cystic fibrosis are diagnosed each year in the U.S. Growing prevalence of such chronic diseases has increased the demand for biobanking equipment significantly. The primary airway cell biobank (PACB) has been collecting biobanking samples since 2009 and provides primary airway epithelial cells from normal donors. Thus, these factors are expected to drive growth of the global biobanking equipment market. Furthermore, technological advancements in stem cell and regenerative medicine are expected to propel the global biobanking equipment market growth in the near future.

However, a stringent regulatory framework imposed by governing authorities is expected to hamper the global biobanking equipment market growth in the near future. Among regions, North America is expected to witness significant growth in the global biobanking equipment market. This is owing to the presence of robust healthcare infrastructure in the region. Furthermore, Europe is expected to register a robust growth rate, owing to growing emphasis on research and development activities for treatment and diagnosis.

Key companies involved in the global biobanking equipment market are Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Bio-Techne Corporation, Stemcell Technologies Inc., Brooks Automation, Stemcell Technologies Inc., Hamilton Company, QIAGEN N.V., Merck KGaA, and Lonza Group.

For instance, in August 2020, Brooks Life Sciences, a subsidiary of Brooks Automation, launched BioStore IIIv, an automated next-generation alternative to manual -80°C mechanical freezers.

Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region